Skip to main content
OpenTrials

Clinical trial condition

Salivary Gland Neoplasms

Explore clinical trials studying Salivary Gland Neoplasms. Study availability and eligibility vary by location and protocol.

190 public trials 22 recruiting studies
Refine in advanced search Browse all conditions

Salivary Gland Neoplasms trial results

Recruiting

DESTINY-PANTUMOUR04

NCT07124000

Conditions
Adenocarcinoma, Adenocarcinoma (NOS), Adnexal Diseases, +116 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Bullhead City, Arizona, United States
  • Research Site Casa Grande, Arizona, United States
  • Research Site San Diego, California, United States
View all 18 locations
View Trial Details
Recruiting

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

NCT06695845

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +64 more
Locations
  • Arizona Oncology Associates, PC - NAHOA Prescott, Arizona, United States
  • Rocky Mountain Cancer Center Littleton, Colorado, United States
  • Florida Cancer Specialists - South Fort Myers, Florida, United States
  • Florida Cancer Specialists - Lake Nona Orlando, Florida, United States
View all 28 locations
View Trial Details
Recruiting

Integrated Cancer Repository for Cancer Research

NCT02012699

Conditions
Abdominal Neoplasms, Adenoma, Adenomatous Polyposis Coli, +195 more
Locations
  • Advent Health Greenwood Village, Colorado, United States
  • Hartford HealthCare Cancer Institute at Manchester Medical Hospital Manchester, Connecticut, United States
  • Florida Hospital Memorial Medical Center Daytona Beach, Florida, United States
  • Florida Hospital DeLand DeLand, Florida, United States
View all 42 locations
View Trial Details
Recruiting

Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers

NCT05408845

Conditions
Head and Neck Neoplasms, Metastatic Salivary Gland Carcinoma, Mouth Diseases, +10 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Kaiser Permanente Dublin Dublin, California, United States
  • Kaiser Permanente-Fremont Fremont, California, United States
View all 152 locations
View Trial Details
Recruiting

A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours

NCT04969835

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +33 more
Locations
  • Memorial Sloan Kettering Cancer Center New York, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Fred Hutchinson Cancer Center Seattle, Washington, United States
  • The Beatson West of Scotland Cancer Centre, NHS Greater Glasgow & Clyde Glasgow, United Kingdom
View Trial Details
Recruiting

Oropharynx (OPX) Biomarker Trial

NCT06356272

Conditions
Carcinoma, Carcinoma, Squamous Cell, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +29 more
Locations
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
View Trial Details
Recruiting

Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas

NCT04620187

Conditions
HER2 Gene Mutation, Head and Neck Neoplasms, Mouth Diseases, +7 more
Locations
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
  • University of Chicago Chicago, Illinois, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 13 locations
View Trial Details
Recruiting

The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers

NCT05483374

Conditions
Head and Neck Cancer, Head and Neck Neoplasms, Middle Ear Carcinoma, +22 more
Locations
  • Masaryk Memorial Cancer Institute Brno, Czechia
  • University Hospital Essen Essen, Hesse, Germany
  • IRCCS Ospedale Policlinico San Martino Genova, Italy
  • IRCCS Ospedale San Raffaele Milan, Milano, Italy
View Trial Details

Related conditions